InfoErbe

Schisandra

Schisandra chinensis (Turcz.) Baillon

Tue, 31 Jan 2006 10:29:37 +0100

Bibliografia

  • Ahumada F, Hermosilla J, Hola R et al. “Studies on the effect of Schisandra chinensis on horses submitted to exercise and maximum effort”. Phytotherapy Research 1989; 3(5): 175-179
  • Ahumada F, Trincado MA, Arellano JA. “Effects of certain adaptogenic plant extracts on drug-induced narcosis in female and male mice” Phytotherapy Research 1991; 5(1): 29-31
  • Akbar N, Tahir RA, Santoso WD et al. “Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients”. Chinese Medical Journal 1998; 111(3): 248-251
  • Amaryan G, Astvatsatryan V, Gabrielyan E, Panossian A, Panosyan V, Wikman G. “Double blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard®—a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with familial Mediterranean fever”. Phytomedicine 2003; 10:271–285.
  • American Herbal Pharmacopoeia “Schisandra berry – Schisandra chinensis: analytical, quality control, and therapeutic monograph” Santa Cruz, American Herbal Pharmacopoeia, 1999
  • Bensky D, Gamble A Chinese Herbal Medicine: Materia Medica. Seattle: Eastland Press, 1986
  • Bone K A clinical guide to blending liquid herbs. Churchill Livingstone, 2003
  • Brekhman I, Dardymov IV. Annual Review of Pharmacology 1969; 9: 419-430 citato in American Herbal Pharmacopoeia 1999
  • Chang HM, But PP. Pharmacology and Applications of Chinese Materia Medica, Volume I. Singapore: World Scientific Publishing, 1987
  • Pharmacopoeia Commission of the People’s Republic of China. Pharmacopoeia of the People’s Republic of China, English Edition, Volume I. Beijing: Chemical Industry Press, 1997
  • Fulder S. The Root of Being: Ginseng and the Pharmacology of Harmony. London: Hutchinson, 1980
  • Gaistruk AN, Taranovskij KL “The treatment of arterial hypotension in pregnant women using Schizandra chinensis.” Urg Probl Obstet Gynecol L’vov 1968; 1:183-186, Citato in American Herbal Pharmacopoeia 1999
  • Geng Junying, Huang Wenquan, Ren Tianchi e Ma Xiufeng Practical Traditional Chinese Medicine and Pharmacology: Medicinal Herbs. New World Press, Pechino 1991
  • Hancke J, Burgos R, Caceres D et al. “Reduction of serum hepatic transaminases and CPK in sport horses with poor performance treated with a standardised Schisandra chinensis fruit extract” Phytomedicine 1996; 3(3): 237-240
  • Hancke J, Burgos R,Wikman G et al. “Schisandra chinensis, a potential phytodrug for recovery of sport horses” Fitoterapia 1994; 65(2): 113-118
  • Hancke JL, Wikman G, Hernandez DE. “Antidepressant activity of selected natural products” Planta Medica 1986; 52: 542-543
  • Hikino H, Kiso Y, Taguchi H et al. “Antihepatotoxic actions of lignoids from Schisandra chinensis fruits” Planta Medica 1984; 50(3): 213-218
  • Hikino H, Kiso Y. In: Wagner H, Hikino H, Farnsworth NR (eds.). Economic and Medicinal Plant Research, Volume 2. London: Academic Press, 1988
  • Hong YH. Oriental Materia Medica: A Concise Guide. Long Beach, CA: Oriental Healing Arts Institute; 1986
  • Ip SP, Ko KM. “The crucial antioxidant action of schisandrin B in protecting agaist carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene” Biochemical Pharmacology 1996; 52(11): 1687-1693
  • Ip SP, Mak DH, Li PC et al. Effect of a lignan-enriched extract of Schisandra chinensis on aflatoxin B1 and cadmium chloride-induced hepatotoxicity in rats. Pharmacology and Toxicology 1996; 78(6): 413-416
  • Ip SP, Poon MK, Che CT et al. Schisandrin B protects against carbon tetrachloride toxicity by enhancing the mitochondrial glutathione redox status in mouse liver. Biology and Medicine 1996; 21(5): 709-712
  • Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T. “Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract” Drug Metab Dispos 2004; 32: 1351–8
  • Iwata H, Tezuka Y, Usia T, Kadota S, Hiratsuka A, and Watabe T “Inhibition of human liver microsomal CYP3A4 and CYP2D6 by extracts from 78 herbal medicines”. J Trad Med 2004; 21:42-50.
  • Jiaxiang N, Fujii K, Sato N et al. “Inhibitory effect of gomisi on reductive metabolism of halotane” Journal of Applied Toxicology 1993; 13(6): 385- 388
  • Jung KY, Lee IS, Oh SR, Kim DS, Lee HK “Lignans with platelet activating factor antagonist activity from Schisandra chinensis (Turcz.) Baill.”. Phytomedicine 1997; 4(3):229-31
  • Kiso Y, Tohkin M, Hikino H et al. “Mechanism of antihepatotoxic activity of wuweizisu C and gomisin A”. Planta Medica 1985; 51(4): 331-334
  • Ko KM, Ip SP, MKT Poon et al. “Effect of a lignan-enriched Fructus schisandrae extract on hepatic glutathione in rats: protection agaist carbon tetrachloride toxicity” Planta Medica 1995; 61(2): 134-137
  • Leung AY, Foster S Enciclopedia delle piante medicinali utilizzate negli alimenti, nei farmaci e nei cosmetici. Aporie, 1999
  • Li LN. Abstracts of Chinese Medicines 1989; 3(4): 414-428
  • Li PC, Mak DHF, Poon MKT, Ip SP, Ko KM “Myocardial protective effect of Sheng Mai San (SMS) and a lignan-enriched extract of Fructus schisandrae, in vivo and ex vivo”. Phytomedicine 1996; 3(2):217-21
  • Li Y, Paranawithana SR, Yoo JS et al. “Induction of liver microsomal cytochrome P-450 2B1 by dimethyl diphenyl bicarboxylate in rats”. Chung Kuo Yao Li Hsueh Pao 1992; 13(6): 485-490
  • Liu GT. “Pharmacological actions and clinical use of Fructus Schizandrae”. Chin Med J 1989;102:740-749
  • Liu GT. In: Chang HM, Yeung HW, Tso WW et al (eds). Advances in Chinese Medicinal Materials Research. Singapore: World Scientific, 1985
  • Liu KT, Cresteil T, Columelli S et al. “Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. II. Induction of phenobarbital-like hepatic monooxygenases”. Chem Biol Interact 1982; 39(3): 315-330
  • Liu KT, Lesca P. “Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotic metabolism and mutagenicity”.Chem Biol Interact 1982; 39(3): 301-314
  • Liu KT, Lesca P. “Pharmacological properties of dibenzo[a,c]cycloctene derivatives isolated from Fructus Schizandrae chinsesis III. Inhibitory effects on carbon tetrachloride induced lipid peroxidation, metabolism and covalent binding of CCl4 to lipids”. Chem Biol Interact 1982;41:39-47
  • Lu H, Liu GT. “[Effects of schizandrin B and schisanhenol on drug metabolizing-phase II enzymes and estradiol metabolism]” Chung Kuo Yao Li Hsueh Pao 1990; 11(4): 331-335
  • Lupandin AV 1966, citato in American Herbal Pharmacopoeia 1999.
  • Lupandin AV “Adaptation to extreme natural and technogenic factors in trained and untrained people under the effect of adaptogens” Fiziol Cheloveka 1990; 16(3):114-119
  • Lupandin AV, Lapaev II 1981, citato in American Herbal Pharmacopoeia 1999
  • Mabberly, DJ The plant book: A portable dictionary of the vascular plants. 2nd edition. Cambridge University Press, 1997
  • Mak DH, Ip SP, Li PC et al. “Effects of Schisandrin B and alpha-tocopherol on lipid peroxidation, in vitro and in vivo”. Molecular and Cellular Biochemistry 1996; 165(2): 161-165
  • Mak DH, Ko KM. “Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant/detoxification system in streptozotocin-induced short-term diabetic rats: effects of insulin and Schisandrin B treatment” Molecular and Cellular Biochemistry 1997; 175(1-2): 225-232
  • McGuffin M, Hobbs C, Upton R e Goldberg A (eds.) AHPA botanical safety handbook. CRC Press, 1997.
  • Mills S, Bone K Principles and Practice of Phytotherapy. Churchill Livingstone, 2000
  • Mills S, Bone K The essential guide to herbal safety. Churchill Livingstone, 2005
  • Narimanian M, Badalyan M, Panosyan V, Gabrielyan E, Panossian A, Wikman G, Wagner H “Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia”. Phytomedicine 2005; 12(10):723-9.
  • Ono H, Matsuzaki Y,Wakui Y et al. “Determination of schizandrin in human plasma by gas chromatography – mass spectrometry” Journal of Chromatography B: Biomedical Applications 1995; 674(2): 293-297
  • Panossian AG, Oganessian AS, Ambartsumian M et al. “Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva” Phytomedicine 1999; 6(1): 17-26
  • Peng HL, Chen DF, Lan HX et al. “Anti-lipid peroxidation of gomisin J on liver mitochondria and cultured myocardial cells”. Chung Kuo Yao Li Hsueh Pao 1996; 17(6): 538-541
  • Pharmacopoeia Commission of the People’s Republic of China. Pharmacopoeia of the People’s Republic of China, English Edition, Volume I. Beijing: Chemical Industry Press, 1997: p 77
  • Rehder A Manual of cultivated trees and shrubs 2nd edition. Macmillan, New York, 1954
  • Sandberg F. Schisandrae Fructus Wu Wei Zi Gothenburg, 1993. citato in American Herbal Pharmacopoeia 1999
  • Trifonova AT “Stimulation of labor activity using Schisandra chinensis”(1954) Akush Ginekol 4:19-22, citato in American Herbal Pharmacopoeia (1999)
  • Wang JP, Raung SL, Hsu MF, Chen CC “Inibition by gomisin C (a lignan from Schisandra chinensis) of the respiratory burst of rat neutrophils.” Br J Pharmacol 1994; 113 (3):945-53
  • Zhang L, Niu X. “Effects of schizandrol A on monoamine neuotransmitters in the central nervous system” Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1991; 13(1): 13-16
  • Zhang TM,Wang BE, Liu GT. “Effect of schisandrin B on lipoperoxidative damage to plasma membrane of rat liver in vitro”. Chung-Kuo Yao Li Hsueh Pao 1992; 13(3): 255-258
  • Zhu B, Liu GT. Zhonggue Yaolixue Yu Dulixue Zazhi 1996; 10(4): 260-266
Tue, 31 Jan 2006 10:29:37 +0100

Licenza Creative Commons
Il database InfoErbe
è pubblicato con
Licenza Creative Commons

Marco Valussi
Luciano Posani

Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved. Mambo is Free Software released under the GNU/GPL License.